Grifols SA (GIFLF)
12.72
0.00 (0.00%)
USD |
OTCM |
Nov 17, 16:00
Grifols Price to Book Value : 1.317 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.317 |
| November 16, 2026 | 1.317 |
| November 13, 2026 | 1.317 |
| November 12, 2026 | 1.317 |
| November 11, 2026 | 1.317 |
| November 10, 2026 | 1.317 |
| November 09, 2026 | 1.317 |
| November 06, 2026 | 1.317 |
| November 05, 2026 | 1.317 |
| November 04, 2026 | 1.268 |
| November 03, 2026 | 1.268 |
| November 02, 2026 | 1.268 |
| October 30, 2026 | 1.092 |
| October 29, 2026 | 1.092 |
| October 28, 2026 | 1.092 |
| October 27, 2026 | 1.092 |
| October 26, 2026 | 1.092 |
| October 23, 2026 | 1.092 |
| October 22, 2026 | 1.092 |
| October 21, 2026 | 1.092 |
| October 20, 2026 | 1.092 |
| October 19, 2026 | 1.092 |
| October 16, 2026 | 1.092 |
| October 15, 2026 | 1.092 |
| October 14, 2026 | 1.092 |
| Date | Value |
|---|---|
| October 13, 2026 | 1.092 |
| October 12, 2026 | 1.152 |
| October 09, 2026 | 1.152 |
| October 08, 2026 | 1.152 |
| October 07, 2026 | 1.152 |
| October 06, 2026 | 1.152 |
| October 05, 2026 | 1.152 |
| October 02, 2026 | 1.152 |
| October 01, 2026 | 1.152 |
| September 30, 2026 | 1.152 |
| September 29, 2026 | 1.195 |
| September 28, 2026 | 1.195 |
| September 25, 2026 | 1.195 |
| September 24, 2026 | 1.195 |
| September 23, 2026 | 1.195 |
| September 22, 2026 | 1.195 |
| September 21, 2026 | 1.195 |
| September 18, 2026 | 1.195 |
| September 17, 2026 | 1.195 |
| September 16, 2026 | 1.195 |
| September 15, 2026 | 1.195 |
| September 14, 2026 | 1.216 |
| September 11, 2026 | 1.216 |
| September 10, 2026 | 1.216 |
| September 09, 2026 | 1.189 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pharma Mar SA | 4.671 |
| Oryzon Genomics SA | 2.015 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.06 |
| Anika Therapeutics, Inc. | 1.251 |
Price to Book Value Related Metrics
| PE Ratio | 15.32 |
| PS Ratio | 0.9814 |
| PEG Ratio | 0.4344 |
| Price to Free Cash Flow | 11.30 |
| Price | 12.72 |
| Earnings Yield | 6.53% |
| Market Cap | 8.657B |
| PEGY Ratio | 0.4098 |
| Operating PE Ratio | 5.983 |
| Normalized PE Ratio | 15.32 |